ScaleUp Group, a leading specialist in securing Series A funding for B2B SaaS scaleups, is pleased to report the successful completion of KAI Conversations’ latest funding round. The interim Series A raise marks an important milestone for the AI-driven conversation intelligence platform, in which ScaleUp Group also co-invested.
The company’s commitment to supporting high-growth technology companies also extends to its clients, as KAI Conversations and Hello Neighbour are set to participate in the upcoming Technology Scale Up Showcase on Thursday, 6th February.
Organised by the Entrepreneurship Panel of the Worshipful Company of Information Technologists (WCIT) on behalf of the Lord Mayor, the event aims to connect the UK’s most promising technology companies with a City audience for funding and business opportunities. It also serves as a platform to showcase the transformative impact of technology on economic growth and innovation.
“We are thrilled to have played a role in KAI Conversations’ latest funding round, which further validates their leadership in AI-driven pharmaceutical engagement,” said John O’Connell, Executive Chairman and Founder of ScaleUp Group. “The participation of our clients in this prestigious event highlights the exceptional quality of businesses we support and their potential to shape the future of technology-driven growth.”
ScaleUp Group, with its team of 30+ partners, works closely with each client to provide strategic guidance and co-invest alongside institutional investors. The company also offers ongoing post-investment support to ensure high-growth technology companies secure funding on the best terms from the right sources to accelerate their growth and success.
KAI Conversations, the world’s leading AI-driven conversation intelligence platform for pharmaceutical field engagement, enables pharmaceutical representatives to improve their interactions with healthcare professionals through real-time insights and coaching. The company operates in multiple languages across major markets and partners with leading pharmaceutical companies to enhance their field force effectiveness and drive better healthcare outcomes.
Hello Neighbour, powered by technology and driven by people, is a property letting and management company that is simplifying the process for landlords and tenants. With no renewal fees, extra fees, or maintenance mark-ups, the company is making property letting faster, simpler, and more affordable.
For further information, please contact: andrea.goodkind@scaleupgroup.co.
About ScaleUp Group:
ScaleUp Group specialises in securing Series A funding for B2B SaaS scaleups. Backed by a team of 30+ partners, each a former entrepreneur who has successfully built and exited their own business, the company provides strategic guidance, co-invests alongside institutional investors, and offers ongoing post-investment support. With an extensive network and hands-on expertise, ScaleUp Group ensures that high-growth technology companies secure funding on the best terms from the right sources to accelerate their growth and success. https://scaleupgroup.co/
About KAI Conversations:
KAI Conversations is the leading AI-driven conversation intelligence platform specifically designed for global pharmaceutical field engagement. The company’s technology enables pharmaceutical representatives to improve their healthcare professional interactions through real-time insights and coaching. Operating in multiple languages across major markets, KAI partners with leading pharmaceutical companies to enhance their field force effectiveness and drive better healthcare outcomes. https://kaiconversations.com/
About Hello Neighbour:
Powered by tech, driven by people, Hello Neighbour is a property letting and management company built for today. With no renewal fees, no extra fees, and no maintenance mark-ups, the company is making property letting simpler, faster, and more affordable for every landlord and tenant they serve. https://www.hello-neighbour.com/
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.